Xuebei An Selected Research

Capecitabine (Xeloda)

10/2020

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuebei An Research Topics

Disease

1	Hypocalcemia 01/2023
1	Hypoparathyroidism 01/2023
1	Brain Neoplasms (Brain Tumor) 10/2020
1	Breast Neoplasms (Breast Cancer) 10/2020
1	Neoplasms (Cancer) 11/2016
1	Adenocarcinoma of Lung 11/2016
1	Carcinogenesis 11/2016

Drug/Important Bio-Agent (IBA)

1	CalciumIBA 01/2023
1	Vitamin D FDA LinkGeneric 01/2023
1	Parathyroid Hormone (Parathormone)IBA 01/2023
1	Investigational DrugsIBA 01/2023
1	tucatinibIBA 10/2020
1	human ERBB2 proteinIBA 10/2020
1	Trastuzumab (Herceptin)FDA Link 10/2020
1	Capecitabine (Xeloda)FDA Link 10/2020
1	Messenger RNA (mRNA)IBA 11/2016
1	Proteins (Proteins, Gene)FDA Link 11/2016
1	Biomarkers (Surrogate Marker)IBA 11/2016

Therapy/Procedure

1	Therapeutics 01/2023